QVT Financial’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

QVT Financial’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-69,122	Closed	-$8.14M	–	95
2015 Q3	$8.14M	Sell	69,122 -129,124	-65%	-$16.9M	0.28%	55
2015 Q2	$15.3M	Sell	198,246 -86,137	-30%	-$5.65M	0.23%	43
2015 Q1	$16.5M	Sell	284,383 -89,570	-24%	-$3.8M	0.92%	28
2014 Q4	$12.1M	Sell	373,953 -246,850	-40%	-$7.41M	0.6%	45
2014 Q3	$15.2M	Sell	620,803 -505,236	-45%	-$10.3M	0.78%	41
2014 Q2	$20M	Sell	1,126,039 -49,864	-4%	-$803K	1.08%	33
2014 Q1	$23.5M	Sell	1,175,903 -46,600	-4%	-$904K	1.35%	27
2013 Q4	$20.5M	Sell	1,222,503 -135,800	-10%	-$1.88M	1.2%	35
2013 Q3	$14.4M	Hold	1,358,303	–	–	0.98%	34
2013 Q2	$7.59M	Buy	+1,358,303	New	+$8.22M	0.51%	45

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QVT Financial's ANAC Position: Q4 2015 in Review

QVT Financial sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 69,122 shares — an estimated $8.14M sold.

QVT Financial first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $23.5M in Q1 2014. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

QVT Financial reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
QVT Financial sold 69,122 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $8.14M.
QVT Financial first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
QVT Financial's ANACOR PHARMACEUTICALS INC COM position peaked at $23.5M in Q1 2014.
214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on QVT Financial's 13F filing for Q4 2015, filed 16 Feb 2016.